Scientists are developing universal vaccines designed to protect against multiple pathogens with a single jab. Current vaccines often fall short when facing fast-evolving viruses like influenza and covid-19. The annual flu vaccine must be reformulated each year based on predictions about which strains will dominate, a process that proved inadequate when the H3N2 strain mutated after WHO selection in 2025.

This limitation became painfully clear during the covid-19 pandemic, when scientists raced to develop effective vaccines against a novel coronavirus. The flu vaccine's shortcomings are particularly frustrating - in 2025, unexpected mutations in the H3N2 strain led to an early and severe flu season across America and Europe despite vaccination efforts. These failures highlight the urgent need for more adaptable immunization strategies.

Universal vaccine research aims to overcome these challenges by targeting conserved viral elements that remain stable across variants. If successful, these everything vaccines could provide lasting protection against multiple strains and even different virus families. The approach represents a fundamental shift from today's reactive vaccine development to proactive, broad-spectrum immunization that could better prepare humanity for future pandemics.